Compare TXG & AIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXG | AIV |
|---|---|---|
| Founded | 2012 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.2B |
| IPO Year | 2019 | 1994 |
| Metric | TXG | AIV |
|---|---|---|
| Price | $15.58 | $5.80 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 1 |
| Target Price | ★ $14.96 | $10.00 |
| AVG Volume (30 Days) | ★ 2.6M | 1.4M |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | ★ 48.92% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.72 |
| Revenue | ★ $641,814,000.00 | $210,889,000.00 |
| Revenue This Year | $4.50 | $6.96 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.71 |
| Revenue Growth | 1.92 | ★ 39.67 |
| 52 Week Low | $6.78 | $5.24 |
| 52 Week High | $20.34 | $9.29 |
| Indicator | TXG | AIV |
|---|---|---|
| Relative Strength Index (RSI) | 42.57 | 55.11 |
| Support Level | $17.32 | $5.58 |
| Resistance Level | $18.38 | $5.62 |
| Average True Range (ATR) | 1.02 | 0.07 |
| MACD | -0.41 | 0.05 |
| Stochastic Oscillator | 1.94 | 98.00 |
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.